Latest News for: hematological malignancies

Edit

Medical Devices: Hematology and Pathology Devices; Classification of the Fluorescence In Situ Hybridization-Based Detection of Chromosomal Abnormalities from Patients with Hematologic Malignancies (The eRulemaking Program)

Public Technologies 26 Jun 2025
A fluorescence in situ hybridization (FISH)-based detection of chromosomal abnormalities from patients with hematologic malignancies is used to detect chromosomal abnormalities in human specimens from patients with hematologic malignancies.
Edit

Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025

PR Newswire 12 Jun 2025
... hematologic oncology assets—golidocitinib and DZD8586—at the 2025 European Hematology Association (EHA) Annual Congress and the 18th International Conference on Malignant Lymphoma (ICML).
Edit

Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA in India to Advance Treatment of Hematological Malignancies (Glenmark Pharmaceuticals Limited)

Public Technologies 09 Jun 2025
) Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to Advance Treatment of Hematological Malignancies ... approved in India for the treatment of five distinct B-cell malignancies.
Edit

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies

Nasdaq Globe Newswire 29 May 2025
Novel approach targeting KAT2A/B with preclinical validation across multiple cancer models and tumor types. Novel approach targeting KAT2A/B with preclinical validation across multiple cancer models and tumor types ... .
Edit

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

Fort Wayne Journal Gazette 27 May 2025
DZD8586 demonstrated significant anti-tumor efficacy in heavily ...
  • 1

Article Search

tools
×
×
×
×